Mutations in Mammalian Tolloid-Like 1 Gene Detected in Adult Patients with ASD

Total Page:16

File Type:pdf, Size:1020Kb

Mutations in Mammalian Tolloid-Like 1 Gene Detected in Adult Patients with ASD European Journal of Human Genetics (2009) 17, 344 – 351 & 2009 Macmillan Publishers Limited All rights reserved 1018-4813/09 $32.00 www.nature.com/ejhg ARTICLE Mutations in mammalian tolloid-like 1 gene detected in adult patients with ASD Paweł Stan´ czak1, Joanna Witecka2, Anna Szydło2, Ewa Gutmajster2, Małgorzata Lisik2, Aleksandra Augus´ciak-Duma2, Maciej Tarnowski2, Tomasz Czekaj2, Hanna Czekaj2 and Aleksander L Sieron´ *,2 1Swietokrzyskie Center for Cardiology, Regional Hospital, Kielce, Poland; 2Department of General and Molecular Biology and Genetics, CoE for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, CoE Network, BioMedTech ‘Silesia’, Medical University of Silesia, Katowice, Poland Atrial septal defect (ASD) is an incomplete septation of atria in human heart causing circulatory problems. Its frequency is estimated at one per 10 000. Actions of numerous genes have been linked to heart development. However, no single gene defect causing ASD has yet been identified. Incomplete heart septation similar to ASD was reported in transgenic mice with both inactive alleles of gene encoding mammalian zinc metalloprotease a mammalian tolloid-like 1 (tll1). Here, we have screened 19 ASD patients and 15 healthy age-matched individuals for mutations in TLL1 gene. All 22 exons were analyzed exon by exon for heteroduplex formation. Subsequently, DNA fragments forming heteroduplexes were sequenced. In four nonrelated patients, three missense mutations in coding sequence, and one single base change in the 50UTR have been detected. Two mutations (Met182Leu, and Ala238Val) were detected in ASD patients with the same clinical phenotype. As the second mutation locates immediately upstream of the catalytic zinc-binding signature, it might change the enzyme substrate specificity. The third change, Leu627Val in the CUB3 domain, has been found in an ASD patient with interatrial septum aneurysm in addition to ASD. The CUB3 domain is important for substrate-specific recognition. In the remaining 15 patients as well as in 15 reference samples numerous base substitutions, deletions, and insertions have been detected, but no mutations changing the coding sequence have been found. Lack of mutations in relation to ASD of these patients could possibly be because of genetic heterogeneity of the syndrome. European Journal of Human Genetics (2009) 17, 344–351; doi:10.1038/ejhg.2008.175; published online 1 October 2008 Keywords: atrial septal defect; DNA sequencing; gene mutations; heart defects; heteroduplex analysis; mammalian tolloid-like 1 Introduction defects might result either from factors damaging the Congenital heart defects in general are related to aberrant fetus during development or they can be of genetic development of the circulation system in a fetus. The background. Some environmental factors, drugs, alcohol abuse, and infections contracted by the mother before, or during pregnancy (eg, rubella) may alter heart development.1–6 However, environmental and maternal *Correspondence: Dr AL Sieron, Department of General and Molecular Biology and Genetics, Medical University of Silesia in Katowice, factors have been linked to approximately 2% of con- ul. Medyko´w 18, Bldg. C-1, 40-752 Katowice, Poland. genital heart defects.7 In a significant number of heart Tel: þ 48 32 208 8394; Fax: þ 48 32 208 8382; abnormalities coexistence of a few anomalies has been E-mail: [email protected] Received 5 May 2008; revised 16 July 2008; accepted 29 August 2008; shown in different parts of the circulation system indicat- 1,8 published online 1 October 2008 ing genetic factors. Mutations in TLL1 causing ASD P Stan´czak et al 345 Chromosomal anomalies and single gene defects, how- gene for mutations by heteroduplex detection followed by ever, could be attributed to the background of 8% of DNA sequencing. congenital heart defects.7,9 – 11 Thus, the background of most of the congenital heart defects is still poorly understood. Materials and methods The heart itself and septation of the large vessels begin at Patients the fourth week of fetal development, but the process is not Hospital records of more than 100 cardiological patients completed until shortly after birth. Septation anomalies are have been reviewed for ASD cases. Twenty individuals have linked to abnormal development of endocardial cushions. been identified who fulfill the requirements of this project. They are necessary for completeness of interatrial as well as All of them were informed about procedures related to the interventrical septa. Incomplete interatrial septum is a study. The procedures were conducted in accordance with common feature of such genetic disorders as Noonan, the Institutional Guidelines and Regulations and with the Turner, and Holt-Oram syndromes.10 – 12 Guidelines for the Conduct of Research Involving Human The condition studied here is called atrial septal defect Subjects approved by the appropriate institutional review (ASD) and has some features common with the other just board (IRB) Bioethical Committee of the Silesian Medical listed heart-related syndromes. Currently, the defects University in Katowice, Poland, No. L.dz.NN-013-339/03. related to ASD are corrected during puberty. However, in In addition, appropriate informed consent was obtained the past, when it was untreated, the patients often suffered from the human volunteers. from numerous severe cardiovascular and pulmonary Finally, 19 individuals agreed to participate in the study complications. and they all have been surveyed for medical and family In recent years, results of research with the use of health history. On the basis of the survey’s results and transgenic mice models revealed that a gene named medical records they were divided into three groups tolloid-like 1 (tll1) is critical for septa development in the (Table 1). mouse heart.13 The mice lacking active TLL1 died at mid- As a reference, blood samples from 15 age-matching gestation because of severe blood circulation failure. The volunteers (11 females and 4 males) were used to isolate tll1 gene product is a metalloprotease with domain DNA for genetic analyses. None of the volunteers have had structure identical to one of the alternatively spliced inherited developmental heart conditions. variants of the bmp-1 gene product, mammalian tolloid (mTLD). The mTLD was detected in mammals and some Samples collection and handling other invertebrates.14 – 18 The homologous protein BMP-1 From each patient two blood samples were drawn. One was originally reported by Wozney et al19 in a context of 3 ml sample was mixed with heparin and used for ectopic bone formation in rats when protein extracts from cytogenetic diagnosis to exclude possible chromosomal demineralized bovine bones were used.20 Subsequently, anomalies. The methods for lymphocytes isolation and based on protein domain structure it was classified in the preparation for karyotyping were the classical methods family of astacin, a group of metalloproteases involved described before.35,36 Slides were examined with a Zeiss in embryo development of different species.17,21 – 23 It is Axioskop microscope. Images were obtained using a Sony also commonly accepted that BMP-1 is important for ExwaveHAD digital camera and MultiScanBase software numerous physiological activities acting in seemingly (Computer Scanning System Ltd., PL) with the karyotype unrelated processes, such as extracellular matrix quality option, enabling manual karyotyping. For each patient, a control involving formation and activation of numerous total of 15 metaphases in each of five prepared karyograms factors that act in the regulation of different genetic were examined to determine the number of chromosomes. programs.17 – 21,23 – 32 The second sample of blood (5.0 ml) was mixed with An investigation of different mouse model with ventrical EDTA and used for the isolation of genomic DNA. spetum defect (VSD) but with active tll1 gene indicated that a different mechanism must be involved, possibly PCR conditions related to abnormal cell proliferation and differentia- The DNA for mutation detection was isolated with the use tion.33,34 Developmental defects of tll1À/À embryos seemed of commercial blood mini-kit (A&A Biotechnology, to be exclusively restricted to the heart.13 The comparison Gdansk, Poland) according to supplier instructions. The of the defects with expression of the tll1 revealed, in quality of purified genomic DNA was verified by spectro- normal mice embryo, its elevated expression levels during metry at A260/280 and agarose gel electrophoresis. heart septation. Thus, it is possible that the expression of Fragments of the TLL1 gene were amplified using pairs of TLL1 in humans could also be critical for correct heart primers designed to complement intronic sequences positioning and its proper septation. flanking coding sequences (Table 2). The conditions for Here, we have tested 19 adult individuals with clinically amplification PCR were as follows: step (1) denaturation confirmed ASD by karyotyping and screening of the TLL1 at 951C for 4 min, step (2) denaturation at 951C for 30 s, European Journal of Human Genetics Mutations in TLL1 causing ASD P Stan´czak et al 346 Table 1 Classification of ASD patients based on their individual clinical symptoms Patient number Sex (F/M) Patient’s age (years) Additional defects Group 1: ASD without additional defects 3 M 51 ND 5 M 55 ND 7 M 71 ND 10a M35ND 11 M 52 ND 15 F 57 ND 18 F 52 ND Group 2: ASD with diagnosed aneurysm of interatrial septum and other defects 1 M 70 Aneurysm, heart attack, cerebral stroke, atrial fibrillation, and cardiac pacemaker implantation 4 M 55 Heart attack 6 M 45 Hypertrophic cardiomyopathy 9 M 72 Aneurysm of interatrial septum sinus bradycardia 12 F 58 Asymptomatic aneurysm of interatrial septum 13 F 48 Aneurysm of interatrial septum 17 F 48 Asymptomatic aneurysm of interatrial septum 19 F 62 Artificial mitral valve implantation Group 3: ASD with irregular heart beating rhythm 2 M 52 Atrial fibrillation, cardiac pacemaker implantation 8 M 51 Atrial fibrillation, cardiac pacemaker implantation 14 F 56 Cardiac pacemaker implantation 16 F 67 Atrial fibrillation ASD, atrial septal defect; F, female; M, male; ND, Not determined.
Recommended publications
  • Supplemental Figure 1. Vimentin
    Double mutant specific genes Transcript gene_assignment Gene Symbol RefSeq FDR Fold- FDR Fold- FDR Fold- ID (single vs. Change (double Change (double Change wt) (single vs. wt) (double vs. single) (double vs. wt) vs. wt) vs. single) 10485013 BC085239 // 1110051M20Rik // RIKEN cDNA 1110051M20 gene // 2 E1 // 228356 /// NM 1110051M20Ri BC085239 0.164013 -1.38517 0.0345128 -2.24228 0.154535 -1.61877 k 10358717 NM_197990 // 1700025G04Rik // RIKEN cDNA 1700025G04 gene // 1 G2 // 69399 /// BC 1700025G04Rik NM_197990 0.142593 -1.37878 0.0212926 -3.13385 0.093068 -2.27291 10358713 NM_197990 // 1700025G04Rik // RIKEN cDNA 1700025G04 gene // 1 G2 // 69399 1700025G04Rik NM_197990 0.0655213 -1.71563 0.0222468 -2.32498 0.166843 -1.35517 10481312 NM_027283 // 1700026L06Rik // RIKEN cDNA 1700026L06 gene // 2 A3 // 69987 /// EN 1700026L06Rik NM_027283 0.0503754 -1.46385 0.0140999 -2.19537 0.0825609 -1.49972 10351465 BC150846 // 1700084C01Rik // RIKEN cDNA 1700084C01 gene // 1 H3 // 78465 /// NM_ 1700084C01Rik BC150846 0.107391 -1.5916 0.0385418 -2.05801 0.295457 -1.29305 10569654 AK007416 // 1810010D01Rik // RIKEN cDNA 1810010D01 gene // 7 F5 // 381935 /// XR 1810010D01Rik AK007416 0.145576 1.69432 0.0476957 2.51662 0.288571 1.48533 10508883 NM_001083916 // 1810019J16Rik // RIKEN cDNA 1810019J16 gene // 4 D2.3 // 69073 / 1810019J16Rik NM_001083916 0.0533206 1.57139 0.0145433 2.56417 0.0836674 1.63179 10585282 ENSMUST00000050829 // 2010007H06Rik // RIKEN cDNA 2010007H06 gene // --- // 6984 2010007H06Rik ENSMUST00000050829 0.129914 -1.71998 0.0434862 -2.51672
    [Show full text]
  • Mechanical Forces Induce an Asthma Gene Signature in Healthy Airway Epithelial Cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T
    www.nature.com/scientificreports OPEN Mechanical forces induce an asthma gene signature in healthy airway epithelial cells Ayşe Kılıç1,10, Asher Ameli1,2,10, Jin-Ah Park3,10, Alvin T. Kho4, Kelan Tantisira1, Marc Santolini 1,5, Feixiong Cheng6,7,8, Jennifer A. Mitchel3, Maureen McGill3, Michael J. O’Sullivan3, Margherita De Marzio1,3, Amitabh Sharma1, Scott H. Randell9, Jefrey M. Drazen3, Jefrey J. Fredberg3 & Scott T. Weiss1,3* Bronchospasm compresses the bronchial epithelium, and this compressive stress has been implicated in asthma pathogenesis. However, the molecular mechanisms by which this compressive stress alters pathways relevant to disease are not well understood. Using air-liquid interface cultures of primary human bronchial epithelial cells derived from non-asthmatic donors and asthmatic donors, we applied a compressive stress and then used a network approach to map resulting changes in the molecular interactome. In cells from non-asthmatic donors, compression by itself was sufcient to induce infammatory, late repair, and fbrotic pathways. Remarkably, this molecular profle of non-asthmatic cells after compression recapitulated the profle of asthmatic cells before compression. Together, these results show that even in the absence of any infammatory stimulus, mechanical compression alone is sufcient to induce an asthma-like molecular signature. Bronchial epithelial cells (BECs) form a physical barrier that protects pulmonary airways from inhaled irritants and invading pathogens1,2. Moreover, environmental stimuli such as allergens, pollutants and viruses can induce constriction of the airways3 and thereby expose the bronchial epithelium to compressive mechanical stress. In BECs, this compressive stress induces structural, biophysical, as well as molecular changes4,5, that interact with nearby mesenchyme6 to cause epithelial layer unjamming1, shedding of soluble factors, production of matrix proteins, and activation matrix modifying enzymes, which then act to coordinate infammatory and remodeling processes4,7–10.
    [Show full text]
  • The Extracellular Matrix Phenome Across Species
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.06.980169; this version posted March 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The extracellular matrix phenome across species Cyril Statzer1 and Collin Y. Ewald1* 1 Eidgenössische Technische Hochschule Zürich, Department of Health Sciences and Technology, Institute of Translational Medicine, Schwerzenbach-Zürich CH-8603, Switzerland *Corresponding authors: [email protected] (CYE) Keywords: Phenome, genotype-to-phenotype, matrisome, extracellular matrix, collagen, data mining. Highlights • 7.6% of the human phenome originates from variations in matrisome genes • 11’671 phenotypes are linked to matrisome genes of humans, mice, zebrafish, Drosophila, and C. elegans • Expected top ECM phenotypes are developmental, morphological and structural phenotypes • Nonobvious top ECM phenotypes include immune system, stress resilience, and age-related phenotypes 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.06.980169; this version posted March 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. 1 Abstract 2 Extracellular matrices are essential for cellular and organismal function. Recent 3 genome-wide and phenome-wide association studies started to reveal a broad 4 spectrum of phenotypes associated with genetic variants. However, the phenome or 5 spectrum of all phenotypes associated with genetic variants in extracellular matrix 6 genes is unknown.
    [Show full text]
  • Table S1 the Four Gene Sets Derived from Gene Expression Profiles of Escs and Differentiated Cells
    Table S1 The four gene sets derived from gene expression profiles of ESCs and differentiated cells Uniform High Uniform Low ES Up ES Down EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol 269261 Rpl12 11354 Abpa 68239 Krt42 15132 Hbb-bh1 67891 Rpl4 11537 Cfd 26380 Esrrb 15126 Hba-x 55949 Eef1b2 11698 Ambn 73703 Dppa2 15111 Hand2 18148 Npm1 11730 Ang3 67374 Jam2 65255 Asb4 67427 Rps20 11731 Ang2 22702 Zfp42 17292 Mesp1 15481 Hspa8 11807 Apoa2 58865 Tdh 19737 Rgs5 100041686 LOC100041686 11814 Apoc3 26388 Ifi202b 225518 Prdm6 11983 Atpif1 11945 Atp4b 11614 Nr0b1 20378 Frzb 19241 Tmsb4x 12007 Azgp1 76815 Calcoco2 12767 Cxcr4 20116 Rps8 12044 Bcl2a1a 219132 D14Ertd668e 103889 Hoxb2 20103 Rps5 12047 Bcl2a1d 381411 Gm1967 17701 Msx1 14694 Gnb2l1 12049 Bcl2l10 20899 Stra8 23796 Aplnr 19941 Rpl26 12096 Bglap1 78625 1700061G19Rik 12627 Cfc1 12070 Ngfrap1 12097 Bglap2 21816 Tgm1 12622 Cer1 19989 Rpl7 12267 C3ar1 67405 Nts 21385 Tbx2 19896 Rpl10a 12279 C9 435337 EG435337 56720 Tdo2 20044 Rps14 12391 Cav3 545913 Zscan4d 16869 Lhx1 19175 Psmb6 12409 Cbr2 244448 Triml1 22253 Unc5c 22627 Ywhae 12477 Ctla4 69134 2200001I15Rik 14174 Fgf3 19951 Rpl32 12523 Cd84 66065 Hsd17b14 16542 Kdr 66152 1110020P15Rik 12524 Cd86 81879 Tcfcp2l1 15122 Hba-a1 66489 Rpl35 12640 Cga 17907 Mylpf 15414 Hoxb6 15519 Hsp90aa1 12642 Ch25h 26424 Nr5a2 210530 Leprel1 66483 Rpl36al 12655 Chi3l3 83560 Tex14 12338 Capn6 27370 Rps26 12796 Camp 17450 Morc1 20671 Sox17 66576 Uqcrh 12869 Cox8b 79455 Pdcl2 20613 Snai1 22154 Tubb5 12959 Cryba4 231821 Centa1 17897
    [Show full text]
  • Supplemental Table 1. Complete Gene Lists and GO Terms from Figure 3C
    Supplemental Table 1. Complete gene lists and GO terms from Figure 3C. Path 1 Genes: RP11-34P13.15, RP4-758J18.10, VWA1, CHD5, AZIN2, FOXO6, RP11-403I13.8, ARHGAP30, RGS4, LRRN2, RASSF5, SERTAD4, GJC2, RHOU, REEP1, FOXI3, SH3RF3, COL4A4, ZDHHC23, FGFR3, PPP2R2C, CTD-2031P19.4, RNF182, GRM4, PRR15, DGKI, CHMP4C, CALB1, SPAG1, KLF4, ENG, RET, GDF10, ADAMTS14, SPOCK2, MBL1P, ADAM8, LRP4-AS1, CARNS1, DGAT2, CRYAB, AP000783.1, OPCML, PLEKHG6, GDF3, EMP1, RASSF9, FAM101A, STON2, GREM1, ACTC1, CORO2B, FURIN, WFIKKN1, BAIAP3, TMC5, HS3ST4, ZFHX3, NLRP1, RASD1, CACNG4, EMILIN2, L3MBTL4, KLHL14, HMSD, RP11-849I19.1, SALL3, GADD45B, KANK3, CTC- 526N19.1, ZNF888, MMP9, BMP7, PIK3IP1, MCHR1, SYTL5, CAMK2N1, PINK1, ID3, PTPRU, MANEAL, MCOLN3, LRRC8C, NTNG1, KCNC4, RP11, 430C7.5, C1orf95, ID2-AS1, ID2, GDF7, KCNG3, RGPD8, PSD4, CCDC74B, BMPR2, KAT2B, LINC00693, ZNF654, FILIP1L, SH3TC1, CPEB2, NPFFR2, TRPC3, RP11-752L20.3, FAM198B, TLL1, CDH9, PDZD2, CHSY3, GALNT10, FOXQ1, ATXN1, ID4, COL11A2, CNR1, GTF2IP4, FZD1, PAX5, RP11-35N6.1, UNC5B, NKX1-2, FAM196A, EBF3, PRRG4, LRP4, SYT7, PLBD1, GRASP, ALX1, HIP1R, LPAR6, SLITRK6, C16orf89, RP11-491F9.1, MMP2, B3GNT9, NXPH3, TNRC6C-AS1, LDLRAD4, NOL4, SMAD7, HCN2, PDE4A, KANK2, SAMD1, EXOC3L2, IL11, EMILIN3, KCNB1, DOK5, EEF1A2, A4GALT, ADGRG2, ELF4, ABCD1 Term Count % PValue Genes regulation of pathway-restricted GDF3, SMAD7, GDF7, BMPR2, GDF10, GREM1, BMP7, LDLRAD4, SMAD protein phosphorylation 9 6.34 1.31E-08 ENG pathway-restricted SMAD protein GDF3, SMAD7, GDF7, BMPR2, GDF10, GREM1, BMP7, LDLRAD4, phosphorylation
    [Show full text]
  • Genomic Analysis of a Spinal Muscular Atrophy
    Jiang et al. BMC Medical Genetics (2019) 20:204 https://doi.org/10.1186/s12881-019-0935-3 CASE REPORT Open Access Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report Jianping Jiang1,2†, Jinwei Huang3†, Jianlei Gu1,2,4, Xiaoshu Cai4, Hongyu Zhao1,2* and Hui Lu1,4* Abstract Background: Spinal muscular atrophy (SMA) is a rare neuromuscular disorder threating hundreds of thousands of lives worldwide. And the severity of SMA differs among different clinical types, which has been demonstrated to be modified by factors like SMN2, SERF1, NAIP, GTF2H2 and PLS3. However, the severities of many SMA cases, especially the cases within a family, often failed to be explained by these modifiers. Therefore, other modifiers are still waiting to be explored. Case presentation: In this study, we presented a rare case of SMA discordant family with a mild SMA male patient and a severe SMA female patient. The two SMA cases fulfilled the diagnostic criteria defined by the International SMA Consortium. With whole exome sequencing, we confirmed the heterozygous deletion of exon7 at SMN1 on the parents’ genomes and the homozygous deletions on the two patients’ genomes. The MLPA results confirmed the deletions and indicated that all the family members carry two copies of SMN2, SERF1, NAIP and GTF2H2. Further genomic analysis identified compound heterozygous mutations at TLL2 on the male patient’s genome, and compound heterozygous mutations at VPS13A and the de novo mutation at AGAP5 on female patient’s genome.
    [Show full text]
  • Drosophila and Human Transcriptomic Data Mining Provides Evidence for Therapeutic
    Drosophila and human transcriptomic data mining provides evidence for therapeutic mechanism of pentylenetetrazole in Down syndrome Author Abhay Sharma Institute of Genomics and Integrative Biology Council of Scientific and Industrial Research Delhi University Campus, Mall Road Delhi 110007, India Tel: +91-11-27666156, Fax: +91-11-27662407 Email: [email protected] Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 Running head: Pentylenetetrazole mechanism in Down syndrome 1 Abstract Pentylenetetrazole (PTZ) has recently been found to ameliorate cognitive impairment in rodent models of Down syndrome (DS). The mechanism underlying PTZ’s therapeutic effect is however not clear. Microarray profiling has previously reported differential expression of genes in DS. No mammalian transcriptomic data on PTZ treatment however exists. Nevertheless, a Drosophila model inspired by rodent models of PTZ induced kindling plasticity has recently been described. Microarray profiling has shown PTZ’s downregulatory effect on gene expression in fly heads. In a comparative transcriptomics approach, I have analyzed the available microarray data in order to identify potential mechanism of PTZ action in DS. I find that transcriptomic correlates of chronic PTZ in Drosophila and DS counteract each other. A significant enrichment is observed between PTZ downregulated and DS upregulated genes, and a significant depletion between PTZ downregulated and DS dowwnregulated genes. Further, the common genes in PTZ Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 downregulated and DS upregulated sets show enrichment for MAP kinase pathway. My analysis suggests that downregulation of MAP kinase pathway may mediate therapeutic effect of PTZ in DS. Existing evidence implicating MAP kinase pathway in DS supports this observation.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • A De Novo Splicing Variant Supports the Candidacy of TLL1 in ASD Pathogenesis
    European Journal of Human Genetics (2020) 28:525–528 https://doi.org/10.1038/s41431-019-0524-0 BRIEF COMMUNICATION A de novo splicing variant supports the candidacy of TLL1 in ASD pathogenesis 1 1,2 3 4 1,2,4 Talal Alanzi ● Amal Alhashem ● Khalid Dagriri ● Fatema Alzahrani ● Fowzan S. Alkuraya Received: 14 March 2019 / Revised: 8 September 2019 / Accepted: 17 September 2019 / Published online: 30 September 2019 © European Society of Human Genetics 2019 Abstract Congenital heart disease (CHD) is the most common type of birth defects with family- and population-based studies supporting a strong hereditary component. Multifactorial inheritance is the rule although a growing number of Mendelian forms have been described including candidates that have yet to be confirmed independently. TLL1 is one such candidate that was proposed in the etiology of atrial septal defect (ASD). We describe a girl with congenitally corrected transposition of the great arteries (ccTGA) and ASD secundum whose whole-exome sequencing (WES) revealed a de novo splicing (c.1379-2A>G) variant in TLL1 as well as an inherited truncating variant in NODAL. The identification of this dual molecular diagnosis both supports the candidacy of TLL1 in ASD pathogenesis and highlights the power of WES in 1234567890();,: 1234567890();,: revealing multilocus cardiac phenotypes. Introduction disability, who account for approximately one quarter of cases [6]. Thousands of syndromes that are currently listed Congenital heart disease (CHD) is the most common birth in OMIM feature CHD, and while classical positional defect, affecting ~2% of liver births (1.35 million newborns mapping approaches were key to deciphering their genetic worldwide) and accounting for nearly a third of major causes in the past, the use of genome sequencing over the congenital malformations, and is the leading cause of infant past decade has now become a standard approach that mortality in western countries [1–3].
    [Show full text]
  • Deciphering the Relevance of Bone ECM Signaling
    cells Review Deciphering the Relevance of Bone ECM Signaling Natividad Alcorta-Sevillano y, Iratxe Macías y, Arantza Infante * and Clara I. Rodríguez * Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S/N, Barakaldo, 48903 Bizkaia, Spain; [email protected] (N.A.-S.); [email protected] (I.M.) * Correspondence: [email protected] (A.I.); [email protected] (C.I.R.) These authors contributed equally. y Received: 20 October 2020; Accepted: 7 December 2020; Published: 7 December 2020 Abstract: Bone mineral density, a bone matrix parameter frequently used to predict fracture risk, is not the only one to affect bone fragility. Other factors, including the extracellular matrix (ECM) composition and microarchitecture, are of paramount relevance in this process. The bone ECM is a noncellular three-dimensional structure secreted by cells into the extracellular space, which comprises inorganic and organic compounds. The main inorganic components of the ECM are calcium-deficient apatite and trace elements, while the organic ECM consists of collagen type I and noncollagenous proteins. Bone ECM dynamically interacts with osteoblasts and osteoclasts to regulate the formation of new bone during regeneration. Thus, the composition and structure of inorganic and organic bone matrix may directly affect bone quality. Moreover, proteins that compose ECM, beyond their structural role have other crucial biological functions, thanks to their ability to bind multiple interacting partners like other ECM proteins, growth factors, signal receptors and adhesion molecules. Thus, ECM proteins provide a complex network of biochemical and physiological signals. Herein, we summarize different ECM factors that are essential to bone strength besides, discussing how these parameters are altered in pathological conditions related with bone fragility.
    [Show full text]
  • Insights of Genome Wide Association Studies Into HCV-Related HCC Inas Maged Moaz, Ayat Rushdy Abdallah, Marwa Fekry Yousef and Sameera Ezzat*
    Moaz et al. Egyptian Liver Journal (2020) 10:4 https://doi.org/10.1186/s43066-019-0013-8 Egyptian Liver Journal REVIEW Open Access Main insights of genome wide association studies into HCV-related HCC Inas Maged Moaz, Ayat Rushdy Abdallah, Marwa Fekry Yousef and Sameera Ezzat* Abstract Background: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-mortality globally. Hepatocarcinogenesis is a complex multifactorial process. Host genetic background appeared to play a crucial role in the progression of HCC among chronic hepatitis C patients, especially in the era of Genome Wide Association Studies (GWAS) which allowed us to study the association of millions of single nucleotide polymorphisms (SNPs) with different complex diseases. This article aimed to review the discovered SNPs associated with the risk of HCV- related HCC development which was reported in the published GWA studies and subsequent validation studies and also try to explain the possible functional pathways. Main text: We reviewed the recent GWA studies which reported several new loci associated with the risk of HCV- related HCC, such as (SNPs) in MHC class I polypeptide-related sequence A (MICA), DEP domain-containing 5 (DEPDC5), Tolloid-like protein 1 (TLL1), and human leukocyte antigen (HLA) genes. We also explained the possible underlying biological mechanisms that affect the host immune response pathways. Additionally, we discussed the controversial results reported by the subsequent validation studies of different ethnicities. Conclusions: Although GWA studies reported strong evidence of the association between the identified SNPs and the risk of HCV-related HCC development, more functional experiments are necessary to confirm the defined roles of these genetic mutations for the future clinical application in different populations.
    [Show full text]
  • Cholesterol 25-Hydroxylase on Chromosome 10Q Is a Susceptibility Gene for Sporadic Alzheimer’S Disease
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2005 Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer’s disease Papassotiropoulos, A ; Lambert, J C ; Wavrant-De Vrièze, F ; Wollmer, M A ; von der Kammer, H ; Streffer, J R ; Maddalena, A ; Huynh, K D ; Wolleb, S ; Lütjohann, D ; Schneider, B;Thal,DR Grimaldi, L M E ; Tsolaki, M ; Kapaki, E ; Ravid, R ; Konietzko, U ; Hegi, T ; Pasch, T ; Jung, H ; Braak, H ; Amouyel, P ; Rogaev, E I ; Hardy, J ; Hock, C ; Nitsch, R M Abstract: Alzheimer’s disease (AD) is the most common cause of dementia. It is characterized by beta- amyloid (A beta) plaques, neurofibrillary tangles and the degeneration of specifically vulnerable brain neurons. We observed high expression of the cholesterol 25-hydroxylase (CH25H) gene in specifically vulnerable brain regions of AD patients. CH25H maps to a region within 10q23 that has been previ- ously linked to sporadic AD. Sequencing of the 5’ region of CH25H revealed three common haplotypes, CH25Hchi2, CH25Hchi3 and CH25Hchi4; CSF levels of the cholesterol precursor lathosterol were higher in carriers of the CH25Hchi4 haplotype. In 1,282 patients with AD and 1,312 healthy control subjects from five independent populations, a common variation in the vicinity of CH25H was significantly associated with the risk for sporadic AD (p = 0.006). Quantitative neuropathology of brains from elderly non- demented subjects showed brain A beta deposits in carriers of CH25Hchi4 and CH25Hchi3 haplotypes, whereas no A beta deposits were present in CH25Hchi2 carriers.
    [Show full text]